ABBV vs JNJ — stock comparison
AbbVie Inc. (ABBV) vs Johnson & Johnson (JNJ): price, valuation, margins, growth and Traddx's fundamentals grade, side by side. Free, live data.
On Traddx's fundamentals score, ABBV grades higher (B 63 vs B 62). Not investment advice.
1-year price performance — higher line = stronger return
■ ABBV +19.8%■ JNJ +38.4%Past year, both rebased to 100
| ABBV | JNJ | |
|---|---|---|
| Traddx grade | B (63) | B (62) |
| Price | $267.40 | $254.59 |
| Today | 0.62% | 0.66% |
| P/E | 75.50 | 28.90 |
| Net margin | 9.80% | 22.10% |
| Revenue (TTM) | $64,386.00M | $97,108.00M |
| Debt / equity | — | 1.37 |
| 52-week high | $269.39 | $281.07 |
| 52-week low | $190.75 | $182.94 |
Green = the stronger figure on each row (lower is better for P/E and debt; higher for the rest). Grade is Traddx's own fundamentals score.
Open ABBV live → Open JNJ live →